TAM
MRNA icon

Titleist Asset Management’s Moderna MRNA Stock Holding History

Titleist Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-31,522
Closed -$1.31M – 316
2024
Q4 		$1.31M Sell
31,522
-18,528
-37% -$886K 0.15% 107
2024
Q3 		$3.34M Sell
50,050
-53,394
-52% -$4.9M 0.48% 56
2024
Q2 		$12.3M Buy
103,444
+3,628
+4% +$459K 1.85% 13
2024
Q1 		$10.6M Buy
99,816
+16,502
+20% +$1.66M 1.86% 12
2023
Q4 		$8.29M Buy
83,314
+3,472
+4% +$292K 1.54% 18
2023
Q3 		$8.25M Buy
79,842
+1,275
+2% +$142K 1.69% 14
2023
Q2 		$9.55M Buy
78,567
+1,371
+2% +$183K 1.88% 12
2023
Q1 		$11.9M Buy
+77,196
New +$12.7M 2.51% 6

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Titleist Asset Management's MRNA Position: Q1 2025 in Review

Titleist Asset Management sold out of Moderna (MRNA) in Q1 2025, closing a stake of 31,522 shares — an estimated $1.31M sold.

Titleist Asset Management first reported a position in MRNA in Q1 2023 and held it in 8 quarters. The position peaked at $12.3M in Q2 2024. 693 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • Titleist Asset Management reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
  • Titleist Asset Management sold 31,522 Moderna shares in Q1 2025, an estimated $1.31M.
  • Titleist Asset Management first reported a position in Moderna in Q1 2023 and held it in 8 quarters.
  • Titleist Asset Management's Moderna position peaked at $12.3M in Q2 2024.
  • 693 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on Titleist Asset Management's 13F filing for Q1 2025, filed 15 May 2025.